Detalhe da pesquisa
1.
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Hepatology
; 79(1): 135-148, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505221
2.
Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors.
Clin Gastroenterol Hepatol
; 21(2): 406-414.e7, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124272
3.
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles.
Hepatology
; 76(4): 1121-1134, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220605
4.
High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease.
Liver Int
; 43(7): 1446-1457, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36912787
5.
Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease.
Int J Mol Sci
; 24(7)2023 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37047094
6.
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key.
Int J Mol Sci
; 24(13)2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445895
7.
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.
Int J Mol Sci
; 24(9)2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37175497
8.
NAFLD and type 2 diabetes: A practical guide for the joint management.
Gastroenterol Hepatol
; 46(10): 815-825, 2023 Dec.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36584750
9.
Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis.
J Hepatol
; 77(1): 15-28, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167910
10.
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function.
J Hepatol
; 76(1): 11-24, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34555423
11.
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology.
Liver Int
; 42(8): 1783-1792, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643936
12.
Can NAFLD overwhelm the Spanish healthcare system in the years to come?
Rev Esp Enferm Dig
; 114(1): 5-9, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34962132
13.
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH).
Gastroenterol Hepatol
; 45(9): 724-734, 2022 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-35248669
14.
Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH.
J Hepatol
; 75(1): 34-45, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33571553
15.
National digestive disease specialists survey on cardiovascular risk management in non-alcoholic fatty liver disease in spanish hospitals.
Liver Int
; 41(6): 1243-1253, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527637
16.
Massive impact of coronavirus disease 2019 pandemic on gastroenterology and hepatology departments and doctors in Spain.
J Gastroenterol Hepatol
; 36(6): 1627-1633, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33184937
17.
Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings.
J Hepatol
; 80(3): e121-e123, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37898349
18.
Letter to the Editor: Updated guidance on NAFLD screening.
Hepatology
; 78(5): E89-E90, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199219
19.
LOXL2-A New Target in Antifibrogenic Therapy?
Int J Mol Sci
; 20(7)2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30986934
20.
Deregulated neddylation in liver fibrosis.
Hepatology
; 65(2): 694-709, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28035772